http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102222917-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102222917-B1
titleOfInvention Pharmaceutical composition comprising amlodipine and olmesartan medoxomil
abstract The present invention provides a pharmaceutical composition containing amlodipine (or (S)-amlodipine) or a salt thereof and olmesartan medoxomil or a salt thereof, comprising a combination of polyvinyl alcohol and fumaric acid as a stabilizer. The pharmaceutical composition of the present invention achieves formulation stability with minimal change in dissolution properties even during long-term storage, and also achieves high chemical stability by minimizing the amount of related substances derived from the active ingredient.
priorityDate 2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009175942-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3680404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451932064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9822750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420657199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86590390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56842000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66656967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424552091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453365839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828206

Total number of triples: 45.